Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy-Reference-Cited by-同舟云学术

Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy

Published:2019-02 Issue:2 Volume:7 Page:479-491.e10
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Blumchen Katharina,Trendelenburg Valerie,Ahrens Frank,Gruebl Armin,Hamelmann Eckard,Hansen Gesine,Heinzmann Andrea,Nemat Katja,Holzhauser Thomas,Roeder Martin,Rosenfeld Leonard,Hartmann Oliver,Niggemann Bodo,Beyer Kirsten

Funder

Foundation for the treatment of peanut-allergic patients

The Berlin Sparkasse Foundation for Medicine

DBV

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference42 articles.

1. Prevalence of common food allergies in Europe: a systematic review and meta-analysis;Nwaru;Allergy,2014

2. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants;Osborne;J Allergy Clin Immunol,2011

3. Lessons for management of anaphylaxis from a study of fatal reactions;Pumphrey;Clin Exp Allergy,2000